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Financing innovation
This article intends to analyse the innovation process from the
financing perspective, concretely the benefits companies draw from
public aid for research, development and innovation (R&D&I).
MARC LLOVERAS
Innovation and risk 
Apart from the main mission specified by each
company, a necessary goal is also that of creating
wealth, to which R&D&I projects are to con-
tribute.
Before starting any major project, companies
therefore need to make a cost-benefit analysis to
it. Such an analysis shall include the following
elements:
 Required resources (investment and expendi-
ture, staff, time, etc.)
 An estimate of the future benefit for the com-
pany
 An analysis of technical, legal, intellectual
property or any other risk that may affect the re-
sult of the project
 An overall assessment of the project in order
to obtain the estimated result for the company
in terms of internal rate of return, net current
value or any other adequate assessment method.
The assessment method needs to include the
risk associated to the project (e.g. through a spe-
cific discount rate or option analysis).
 An analysis of the affection of global risks and
the joint risk of R&D&I projects at the company.
A project portfolio with diversified risk reduces
the overall risk without diminishing profitability.
Most companies, especially SMEs, do not have
such processes systematised, which often causes
their projects to fail due to a lack of previous
analysis.
R&D&I investment
Generally speaking, a company’s R&D&I budget
is mostly made up of current expenditure
though it may include a part of fixed assets
(equipment, patents, licences, etc.). In any case,
if a company wishes to have a sound balance, it
should be financed through:
Positive results of the exercise; it is the most
sustainable option as long as the company keeps
a net cash surplus
Capital enlargement by current or new part-
ners
These alternatives do not increase the financial
risk. Additionally, a company also can:
Increase leveraging as long as its repayment
capacity allows to do so. The repayment dead-
lines of additional debt should bear a relation to
a realistic forecast of project benefits.
Collaborate with other companies to carry out
joint projects, thus reducing the individual cost
for each company or implementing projects with
a wider scope.
A company’s R&D&I budget is mostly
made up of current expenditure
though it may include a part of fixed
assets (equipment, patents, licences,
etc.). 
Since these possibilities are usually limited by
different factors, public aid can help the compa-
ny increase its investment volume or raise signif-
icantly its amount of projects.
Public aid for R&D&I
At its meeting in Barcelona in March 2002, the
European Council agreed to increase the Euro-
pean Community’s overall R&D&I expenditure
to 3% of GDP by 2010. It was further decided
that one third of new investment should come
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from the private sector. In this sense, it was
agreed that economic efficiency could be in-
creased through state aid, thus contributing to
sustainable growth and employment.
So despite not complying with Article 87 of the
EC Treaty as to public aid, R&D&I funding is al-
lowed as long as it contributes to increasing
overall R&D&I and competitive distortion is not
considered contrary to the common interest.
This regulation included in the community
framework5 allows for a high degree of aid.6
Companies can finance a big part of R&D&I
projects with public aid. This percentage relates
to the maximum intensity of aid7, which will be
dealt with further on.
At the same time, the community framework re-
quires that aid lines to companies
serve purposes of common interest (e.g.
growth, job creation, improvement of environ-
mental conditions),
have an encouraging effect and thus change
the behaviour of the company,
limit the effect of competitive distortion so the
overall balance is positive.
The community framework further states that
companies receiving aid improve their position
compared to the rest.8 Companies therefore
need to consider that if their competitors inno-
vate and have access to public aid while they do
not, their competitive position may deteriorate.
The best known types of public aid 
are subsidies, but there are other
mechanisms.
The second point limits the project types eligible
for funding: no subsidy may be given for those
activities the company would pursue without
public aid.
State aid to R&D&I is to induce a change of be-
haviour in companies that leads to an increase
of their R&D&I activity and encourages projects
that otherwise would not be done or at least be
subject to more restrictions. That is, companies
should increase their R&D&I activities as to vol-
ume, scope, overall investment and implementa-
tion rate.
Aid types
The best known types of public aid are subsi-
dies, but there are other mechanisms. The main
aid types are the following:
Subsidies
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Chart 1. Public R&D&I project financing
Source: Own research
Small companies Medium-sized companies Big companies
Industrial research1 70% 60% 50%
Experimental development2 45% 35% 25%
Innovation in processes3 and organisation4 35% 25% 15%
The percent rates shown on the chart relates to the maximum intensity of public aid for financing
R&D&I projects at companies.
Refundable advances: a loan for a project, paid
in one or more instalments and whose repay-
ment conditions depend on the project result
Loans at better conditions than on the market,
basically with a bonus on interest rates
Guarantees: the state guarantee allows the
company to obtain a loan at better conditions
than on financial markets9
Risk capital: there may be aid for investors, risk
capital funds or companies receiving investment;
their purpose is to improve capital market effi-
ciency of SMEs10
In Catalonia, companies may opt for different
kinds of funding given directly by the Catalan
and Spanish governments as well as the Euro-
pean Union.
A strong increase of funding in the
form of financial instruments and a
concentration of subsidies on
medium-sized and big projects the
patterns observed in public R&D&I
aid.
The aid a company is considered to obtain is cal-
culated in different ways for each instrument. In
the case of subsidies, it is the sum actually re-
ceived by the company. In the case of subsidised
loans, the company obtains an implicit aid. This
aid amounts to the difference between the inter-
est rate under market conditions and the actual
interest paid by the company for this loan. This
sum is called gross equivalent aid. The loan the
company obtains is higher than that.
We are currently observing two trends in setting
out public R&D&I aid:
 A strong increase of funding in the form of fi-
nancial instruments (loans, guarantees and risk
capital)
 Concentration of subsidies on medium-sized
and big projects, especially joint projects in
which different types of companies and technol-
ogy and research centres participate
There are several factors leading to these trends
but we could point out the need for increasing
funding efficiency and improving access of inno-
vating companies to financing.
Access to financing
One of the points considered crucial in cohesion
policy is to improve access of SMEs to
financing.11
The Government of Catalonia, more precisely
the Ministry of Innovation, Universities and En-
terprise, through CIDEM, as well as the Ministry
of Economy and Finance and the Ministry of
Employment, is implementing an important
package of joint initiatives to improve access of
SMEs to financing, which includes risk capital
funds, loans, guarantees and programmes for
private investors.
CIDEM will create new long-term loan schemes
for R&D&I projects envisaging from strategic to
more modest projects, which will, together with
the subsidies already given by this body, com-
plete the offer to finance R&D&I projects.
The Administration takes over a certain cost
when setting out these financial instruments.
This cost can be an interest rate bonus or, in
other cases, some kind of guarantee. Funding in
the form of long-term loans usually includes an
interest bonus and is therefore offered at a lower
rate than a company may obtain under market
conditions.12
Nevertheless, subsidised loans require the usual
guarantees. It is still frequent that some SMEs
do not take them because cannot produce the
guarantee in spite of mechanisms ensuring ac-
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cess in many cases. There are even companies
that, due to their inability to obtain a guarantee,
make arrangements with financial institutions
from which they obtain a part of their financing
in exchange of using a part of the awarded loan
as a guarantee.
Aid in the form of guarantee is usually given
through mutual guarantee societies. The very ex-
istence of aid does not mean that loans can be
given to companies without repayment capacity,
but funding shall allow the mutual guarantee
society to keep a higher delinquency rate than a
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financial institution may consider adequate
without public aid. This ratio must not be exces-
sive as this could pose a risk to the society itself.
Risk capital and business
angels
In some cases, companies need to increase their
capitalisation to take on high-risk projects, with
capital coming either from existing or new part-
ners.
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Graph 1. 2008 financing scheme
Source: Own research
The graph shows some of the publicly funded capital or quasi-capital financing instruments for
innovating companies.
The capital market for SMEs in Catalonia has
not reached a degree of development compara-
ble to other leading countries yet. Developing
this market is considered a key factor to encour-
age the creation and growth of young innovating
companies.
This market basically consists of two kinds of
players:
Risk capital societies drawing financial re-
sources from private or institutional investors
with the aim of investing temporarily in unlisted
companies. Some financial institutions also have
created instruments to invest in young compa-
nies.
Business angels investing own resources di-
rectly in unlisted companies. They can join to
form networks, organised groups investing indi-
vidually or jointly. There are currently nine busi-
ness angels networks in Catalonia.13
Business angels and risk capital funds usually
look for growing companies. Some are highly
specialised and invest only in technology com-
panies while others have a rather general focus
and spread their investments over different in-
dustries.
There are over forty risk capital
operators in Catalonia investing in
different SME types
This capital market for SMEs has developed
considerably so it can be said that entrepreneurs
creating innovating companies with a strong
growth never had as many financing alternatives
as they do now. However, there are still uncov-
ered segments that are going to be progressively
served by private initiative if they yield a prof-
itability rate adjusted to their risk. The role the
Government of Catalonia plays through CIDEM
and the Catalan Institute of Finance is important
to encourage the creation of new funds and in-
struments to improve this offer.
Graph 1 shows some of the publicly funded cap-
ital or quasi-capital financing instruments for in-
novating companies.
Effects of public aid
on R&D&I
The benefits of public aid for companies is ap-
parent, although it is also true that managing
projects associated to public aid often causes ad-
ditional work.
If we search for R&D&I funding on the CIDEM
Funding and Subsidies Database14 we will find 82
entries. Companies in Catalonia can opt for fund-
ing by the Catalan and Spanish Governments as
well as the European Commission, each with its
distinct conditions, processes and deadlines.
Besides, given the quick and constant change of
target priorities, the change in funding usually
goes at a similar pace in order to satisfy these
needs.
In the case of subsidies and refundable ad-
vances, usually subject to competition processes,
the main variable elements the company has to
work with are the following:
 Differing date of start (publication of orders).
The same funding may be published on different
dates in different years so staying alert and ready
is important.
 Short time to submit projects. Once the call
has been published in the according official
journal, companies have to submit their applica-
tions within short time. Prepared companies will
be able to submit adequate projects within few
weeks.
 Long resolution period. The different adminis-
trations may take a long time (i.e. months) to is-
sue a final resolution that allows the company to
know if it has been given funding.
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 Short execution period. Companies have to
execute the project (and thus spend 100% of eli-
gible funds) over a given period, but the compa-
ny often needs to start the project before know-
ing if it will be given funding or not. If it waits, it
may not have enough time to fully execute the
project. Otherwise, if it decides to start it can
turn out to be left without funding.
 Long payment period. Several months may
pass from the moment a company finishes the
project to the time funding is finally paid out. In
some cases an advance payment may be asked
for though a financial guarantee will usually be
necessary to obtain it, which is also a slow
process.
If subsidised loans are subject to competition,
the disadvantages may be the same as those
mentioned for subsidies. In case the call is open
(i.e. loans are awarded as companies submit
their application) it may happen that there is a
long resolution period (months) if aid is given
through public bodies.
A proposal 
for approaching 
R&D&I funding 
Despite this seeming complexity, it is not diffi-
cult to receive and manage funding. In the fol-
lowing we will show some key aspects for set-
ting out an according strategy. The fact is that
there is an increasing number of companies that
manage to fund a considerable part of their
R&D&I efforts with public support.
The most common error of SMEs is to make a
first attempt to «see what comes out», usually
without devoting enough time nor resources to
it. When they do not receive funding for differ-
ent reasons (mainly because they are submitting
projects that do not comply with requirements
or because they are not competitive enough)
they argue that it is too difficult and forget
about it. This error plus the poor use of public
R&D&I aid in general is due to an incorrect fo-
cus of some companies that could be sum-
marised in a couple of sentences:
«How can we get subsidies for things the com-
pany already does?»
«Since the company does R&D, we need to get
subsidies.»
Despite this seeming complexity, 
it is not difficult to receive and
manage funding. The most common
error of SMEs is to make a first
attempt to «see what comes out»,
usually without devoting enough time
nor resources to it. 
As we said at the beginning, public aid intends
to increase overall R&D&I, which requires a dif-
ferent approach. Public aid is an opportunity to
do a quantum leap in R&D&I. However, compa-
nies could carry out the following activities to
reduce the aforementioned disadvantages:
 Planning and dividing R&D&I into three proj-
ect types:
I. Strategic: in this case, funding can only be ob-
tained if it leads to an increased R&D&I effort
on behalf of the company and public support is
considered necessary
II. Big projects: projects requiring massive invest-
ment, often implemented together with other
companies or technology or research centres and
only feasible with a minimum level of public aid
III. Joint projects with other organisations: com-
panies may be offered to participate in joint
projects that, despite not being strategic to the
company, may be of big value as to knowledge
and experience
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 Identifying calls for which they are eligible
 Identifying other organisations that can col-
laborate in concrete projects
 Making an objective aid budget that should be
included into the overall company budget under
different scenarios as it requires a different de-
gree of R&D&I investment according to how
much aid is received
 Allocating required resources, both internal
and external, to meet the expected targets as to
receiving aid
Like making income, receiving public funding is
nothing else than just another business process,
with a given degree of uncertainty but manage-
able as any other.
Companies may seek advice with
specialised consultants. There is also
funding for preparing R&D&I projects
that facilitate planning and the
submission of applications.
The company needs to plan projects and funding
and be aware of calls for funding. The calls are
not always published on the officially planned
date. Together with short submission deadlines,
this is a reason for which companies that are
generally unprepared miss opportunities.
Companies not having such capacities may seek
advice with specialised consultants. There is also
funding for preparing R&D&I projects that facili-
tate planning and the submission of applications.
On what things does aid
depend?
Current regulations on R&D&I funding limit
public aid to entrepreneurial projects according
to several parameters. It is therefore important
to understand these concepts in order to have
realistic expectations of the funding a company
can obtain.
 Project type: industrial research, experimental
development, process innovation, organisational
innovation.
 Eligible budget: out of the overall budget of
the project submitted by a company, the admin-
istration needs to assess what positions are actu-
ally eligible. For instance, if a company buys a
machine with an operating life of five years and
the period to execute the project submitted is of
one year, only 20% of the cost of the machine
will be considered eligible in case it is used ex-
clusively for R&D&I. Eligible positions may be
different according to each funding scheme. Aid
orders usually fix a minimum eligible budget.
 Maximum intensity: maximum subsidy rate a
company may obtain from the eligible budget. It
depends on different factors such as the project
or company type or if it is an individual or joint
project. This limit affects all subsidies a company
receives for a given project. Although many
companies submit the same project to different
calls managed by different bodies, the funding
bodies and the companies need to make sure
that in no case the maximum rate is exceeded.
Coordination between different administrations
is becoming ever tighter and allows to easier de-
tect an accumulation of aid.
 Awarded subsidy: in the case of financial in-
struments (e.g. loans), the awarded sum is high-
er than the awarded subsidy (gross equivalent
aid). In case of funding given by means of a
competition process, the projects with the worst
grading will probably not receive any aid while
the best could obtain the maximum intensity.
 Justification: a company needs to produce be-
fore the administration a justification for 100%
of eligible positions (eligible budget). The usual
requirement are invoices and receipts, the in-
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voice date being within the period set by the aid
scheme, as well as a technical report.
 Subsidy received: finally, the amount a com-
pany receives. If it is not possible to justify 100%
of the aid, those positions not being totally justi-
fied will be reduced proportionally.
Unfamiliarity with these concepts usually causes
frustration at the company. To set up an objective
budget, an estimate of what the company can
realistically receive is necessary, which requires
knowing about the competency in aid schemes
to which the company applies (awarded funding,
submitted applications), the changes of require-
ments in each scheme as well as the increase or
decrease of the annual scheme budget and of
the number of calls.
Conclusion
Public R&D&I funding available to companies is
an opportunity to do a quantum leap in invest-
ment. Obtaining such aid is just another busi-
ness process. Companies need to make their
project planning, a budget for obtaining aid and
adequate follow-up.
Companies missing such opportunities lose
competitiveness as other competitors, both local
and European, do take them.
For any further information please refer to:
ACC1Ó CIDEM-COPCA
www.cidem.com
Tel. 93 476 72 00
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Notes
1. Community framework for state aid for R&D&I: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2006:323:0001:0026:
EN:PDF.
2. These figures do not apply in all cases as the community framework provides for different limits shown on this chart, according to a
set of parameters.
3. Intensity of aid: gross amount of aid given as a percentage on eligible project costs. All amounts stated are before taxes or other de-
ductions. When aid is awarded in any other form than a subsidy, its amount is considered to be equivalent to a subsidy.
4. Industrial research: planned research or critical studies aimed at acquiring new knowledge and skills that can be useful for develop-
ing new products, processes or services or that allow to improve considerably those already in place. It includes creating components
of complex systems that are needed for industrial research, especially the validation of overall technology. Some types of prototypes
are exempt.
5. Experimental development: acquisition, configuration and use of existing scientific, business or other knowledge with the aim of set-
ting up plans and structures or layouts of new, modified or improved products, processes or services. Related activities may include the
elaboration of projects, layouts, plans and other types of documentation, as long as it is not for commercial use. It further includes the
development of certain types of prototypes and pilot projects as well as experimental production and trial of products, processes and
services, as long as they are not used for industrial applications or commercial purposes. Experimental development does not include
usual or regular modifications on existing products, production lines, manufacturing processes, services or any other current activity,
even if these modifications may be an improvement.
6. Innovation related to processes: application of a new or significantly improved production or supplying method (including significant
change in technology, equipment or IT programmes). However, minor changes or improvements, increase of production or service ca-
pacities by means of introducing manufacturing or logistic systems very similar to those in place, termination of a process, capital re-
placement or enlargement, changes exclusively due to variations of factor prices, customisation, seasonal or other regular changes and
the sale of new or significantly improved products are not considered innovations.
7. Innovation related to organisation: application of a new organisational method to commercial practices, site organisation or external
relations of the company. However, changes in commercial practices, site organisation or external relations based on organisational
methods used at the company, changes of management strategy, mergers and acquisitions, termination of a process, capital replace-
ment or enlargement, changes exclusively due to variations of factor prices, customisation, seasonal or other regular changes and the
sale of new or significantly improved products are not considered innovations.
8. «The main concern related to R&D&I aid to undertakings is that rival undertakings’ dynamic incentives to invest are distorted and
possibly reduced. When an undertaking receives aid, this generally strengthens its position on the market and reduces the return on
investment for other undertakings.» Community framework for state aid for R&D&I.
9. State aid in the form of guarantees. Commission notice on the application of Articles 87 and 88 of the EC Treaty to state aid in the
form of guarantees [Official Journal C 71 of 11.03.2000]:  http://europa.eu/scadplus/leg/en/lvb/l26083.htm.
10. Community guidelines on state aid to promote risk capital investments in small and medium-sized enterprises (2006/C194/02):
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2006:194:0002:0021:EN:PDF.
11. Community strategic guidelines on cohesion (2006/702/EC):
http://ec.europa.eu/regional_policy/sources/docoffic/2007/osc/l_29120061021en00110032.pdf.
12. Communication from the Commission on the revision of the method for setting the reference and discount rates (2008/C 14/02):
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2008:014:0006:01:EN:HTML.
13. CIDEM Directory of Business Angels Networks: http://www.cidem.com/cidem/eng/networks/xip/directori/index.jsp.
14. Funding and Subsidies Database, FISUB: http://www.cidem.com/cidem/eng/services/financing/bbddajuts/index.jsp;
http://www.gencat.cat/finempresa.
